Baird Medical's presence at the AAES 2025 meeting highlights the growing significance of its MWA technology in the evolving landscape of minimally invasive treatment options for endocrine conditions, particularly thyroid nodules. The participation provides an excellent opportunity for the Company to engage with key opinion leaders in endocrine surgery, share clinical updates on its MWA systems, and contribute to discussions on innovative patient care strategies. The AAES Annual Meeting is widely regarded as ...